Compare Abbott Laboratories (ABT) vs Dow Jones Industrial Average ETF (DIA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Dow Jones Industrial Average ETF — how do they compare? Abbott Laboratories trades at $94.9 (market cap $166.94B), while Dow Jones Industrial Average ETF trades at $522.4. The key difference: Abbott Laboratories pays a 2.63% dividend while Dow Jones Industrial Average ETF pays none, and Dow Jones Industrial Average ETF is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | DIA | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | — |
52-Week High | $136.62 | $530.02 |
52-Week Low | $82.57 | $435.72 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
DIA (SPDR Dow Jones Industrial Average ETF Trust) trades at $530.02, up 0.41% with a bullish technical signal from moving averages. The ETF tracks the Dow Jones Industrial Average, which recently surpassed 53,000 for the first time, driven by financials and tech exposure. Recent dividend distributions and strong institutional interest support the positive momentum, though oscillators indicate some overbought conditions with RSI levels above 70.
Outlook remains favorable given the Dow's 8% YTD gain and historical 13.3% average annual returns. Key risks include election-year volatility and potential Fed policy shifts under new Chair Kevin Warsh. Investors benefit from blue-chip diversification, but should monitor technical resistance near $533 and broader market sentiment for sustained upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Dow Jones Industrial Average ETF
The ETF is designed to track the performance of the securities and the stocks in the Dow Jones Industrial Average Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on DIA →
